PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33093222-1	2021	OBJECTIVE: To investigate the association between protease-activated receptor-1 (PAR-1) gene F2R polymorphisms and efficacy of clopidogrel for minor stroke or TIA.	Clopidogrel	127-138	coagulation factor II thrombin receptor	Homo sapiens	50-79	
33093222-1	2021	OBJECTIVE: To investigate the association between protease-activated receptor-1 (PAR-1) gene F2R polymorphisms and efficacy of clopidogrel for minor stroke or TIA.	Clopidogrel	127-138	coagulation factor II thrombin receptor	Homo sapiens	81-86	
33093222-1	2021	OBJECTIVE: To investigate the association between protease-activated receptor-1 (PAR-1) gene F2R polymorphisms and efficacy of clopidogrel for minor stroke or TIA.	Clopidogrel	127-138	coagulation factor II thrombin receptor	Homo sapiens	93-96	
33093222-6	2021	The association between F2R IVSn-14 A/T polymorphism and clopidogrel response was present regardless of the carrier status of the CYP2C19 loss-of-function alleles.	Clopidogrel	57-68	coagulation factor II thrombin receptor	Homo sapiens	24-27	
33093222-8	2021	CONCLUSIONS: Among patients with minor ischemic stroke or TIA who were receiving clopidogrel and aspirin, those carrying the F2R IVSn-14 T allele had a lower rate of recurrent stroke than those who were not.	Clopidogrel	81-92	coagulation factor II thrombin receptor	Homo sapiens	125-128